Captura Biopharma
Captura is developing an orally administered MCM for radionuclide contamination.
Based in AR
🤖
AI Overview
With $66K in lobbying spend across 17 quarterly filings, Captura Biopharma is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2022 to 2025.
$66K
Total Spend
4
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $60K |
| 2023 | $6K |
| 2024 | $0 |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense, Health Issues, Disaster Planning
- •Support Captura Biopharma in educating executive and legislative branch officials and personnel on the current medical countermeasure limitations of existing radionuclide and heavy metal exposure medi
- •Response capabilities related to internal radionuclide contamination.
- •FY2024 NDAA; FY2024 Defense Appropriations
Related Analysis
Related Investigations
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.